Atom Investors LP Aligos Therapeutics, Inc. Transaction History

Atom Investors LP

$782 Million
Q1 2024

A detailed history of Atom Investors LP transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Atom Investors LP holds 34,173 shares of ALGS stock, worth $11,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,173

Holding current value

$11,960

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$0.64 - $1.13 $21,870 - $38,615	34,173 New	34,173 $33,000
Q2 2022 Aug 15, 2022	BUY	$1.04 - $2.14 $23,592 - $48,545	22,685 New	22,685 $27,000

Others Institutions Holding ALGS

# of Institutions

Shares Held

46.2M

Call Options Held

6.11M

Put Options Held

200

Armistice Capital, LLC New York, NY

6.89M
Shares

$2.41 Million
0.09% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.39M
Shares

$2.24 Million
0.18% of portfolio
Deep Track Capital, LP Greenwich, CT

6.1M
Shares

$2.14 Million
0.2% of portfolio
Vivo Capital, LLC Palo Alto, CA

3.55M
Shares

$1.24 Million
0.46% of portfolio
Altitude Crest Partners Inc. Stamford, CT

2.84M
Shares

$995,638
1.19% of portfolio

View Full List

About Aligos Therapeutics, Inc.

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $13.9M
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

More about ALGS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Account